
6.7K
Downloads
178
Episodes
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves. Brought to you by Singular: Building Brilliant Biotechs. Connect with us at: LinkedIn: https://www.linkedin.com/company/singular-biotech/ www.singular-biotech.com
Episodes

3 days ago
Mirko Buchholz, PerioTrap
3 days ago
3 days ago
In this episode of Careers in Discovery, we’re joined by Mirko Buchholz, Co-founder and Managing Director at PerioTrap Pharmaceuticals, a Biotech company on a mission to revolutionize oral health by tackling one of the most widespread and underestimated diseases in the world - periodontitis.
Mirko shares how a passion for chemistry and biology sparked his journey into drug discovery, and how his training in pharmacy gave him the unique ability to translate across scientific disciplines. He takes us through the ups and downs of building PerioTrap, from the science behind their microbiome-preserving approach to gum disease, to winning funding competitions, to a chance investor encounter that doubled their seed round.
We also talk about resilience in Biotech, the realities of raising money for an overlooked therapeutic area, and why Mirko believes patience, curiosity, and adaptability are the essential traits for any scientist considering the leap into entrepreneurship.

Wednesday Apr 16, 2025
Annelise Vuidepot, Immunocore
Wednesday Apr 16, 2025
Wednesday Apr 16, 2025
In this episode of Careers in Discovery, Tom meets with Annelise Vuidepot, Chief Technology Officer and UK Site Head at Immunocore, one of the UK’s most successful Biotech companies.
Annelise was there on day one in 2000, when Immunocore spun out from Oxford University, and she’s been at the heart of the company’s pioneering work in T-cell receptor-based therapies ever since. She shares her story of building a new technology from scratch, the long road to Immunocore’s first approved drug, and how the company continues to evolve and innovate across oncology, infectious disease, and now autoimmunity.
We explore what it takes to lead through 25 years of change, how Immunocore maintained a unified culture through hypergrowth, and why curiosity, resilience, and purpose are the keys to a fulfilling scientific career.

Wednesday Apr 09, 2025
Robert Fletcher, Nanolyx
Wednesday Apr 09, 2025
Wednesday Apr 09, 2025
In this episode of Careers in Discovery, Emma is joined by Robert Fletcher, co-founder and CEO of Nanolyx, a company developing sustainable antimicrobial technologies that could help solve one of the world’s biggest challenges: antimicrobial resistance.
Robert shares his unconventional path into Biotech - from working every entry-level job under the sun to returning to school in his thirties to study Biochemistry. Now leading a start-up while also working full-time in the lab at an early-stage Flagship Pioneering company, he reflects on the mindset needed to navigate entrepreneurship, the importance of mentorship, and why curiosity is more important than technical skills.
We also dive into the science behind Nanolyx’s unique nanoparticle-based technology, why they pivoted from FDA to EPA approval, and how the company is aiming to tackle everything from hospital infections to sustainability in surface disinfection.

Thursday Apr 03, 2025
Søren Bregenholt, Alligator Bioscience
Thursday Apr 03, 2025
Thursday Apr 03, 2025
In this episode of Careers in Discovery, we’re joined by Søren Bregenholt, CEO of Alligator Bioscience, a company developing tumour-directed immunotherapies to treat aggressive cancers such as pancreatic cancer.
Søren shares his journey from academic immunologist to biotech CEO, including pivotal moments in his career - from his experiences at the Pasteur Institute, to building his Biotech education at Symphogen, to navigating the corporate world at Novo Nordisk. He reflects on lessons learned from leadership, fundraising, and decision-making at the top, and the importance of humility, structure, and courage in the face of uncertainty.
We also explore what it really means to be a CEO, why "solving problems is your job," and how to strike the balance between hierarchy and creativity in growing Biotech companies.
A compelling conversation about resilience, reinvention, and leading with clarity in an ever-evolving industry.

Tuesday Apr 01, 2025
Chelsea Trengrove, Neoclease
Tuesday Apr 01, 2025
Tuesday Apr 01, 2025
In this episode of Careers in Discovery, Emma meets with Chelsea Trengrove, CEO & co-founder of Neoclease, a start-up pioneering AI-designed, gene-specific editors that aim to overcome the safety, specificity, and scalability challenges of CRISPR-based therapies.
Chelsea shares how her lifelong fascination with the brain and a PhD in neuroscience evolved into a career at the intersection of deep tech, healthcare, and entrepreneurship. From clinical trials and digital health to strategic partnerships and building a company from the ground up, her journey is a masterclass in adaptability, curiosity, and courage.
She also opens up about the mindset shifts required to become a first-time CEO, the importance of saying yes (even when you’re scared), and why meditation, martial arts, and mentorship have all shaped her leadership style.

Thursday Mar 27, 2025
Ulrika Norin, Serendo Therapeutics
Thursday Mar 27, 2025
Thursday Mar 27, 2025
From a childhood hospital bed to the founding of her own Biotech company, Ulrika Norin’s journey into drug discovery has been anything but conventional. In this episode of Careers in Discovery, we speak with the founder and CEO of Serendo Therapeutics about her mission to transform treatment for autoimmune disease - starting with a breakthrough she made during her PhD.
Ulrika shares how a long-standing fascination with the immune system led her to discover Endothelin A2 as a key regulator of autoimmunity, and how that science laid the foundation for Serendo. She talks openly about the leap from scientist to CEO, the pressures of leadership, and what it really means to build something from scratch.
We also explore her time at Karolinska and Omnio, the importance of mentorship and networks, and why the best advice is to follow your gut - even if the path isn’t linear.
If you're curious about what it takes to spin out an idea into a company, balance passion with pressure, and lead with authenticity, this is one for you.

Tuesday Mar 25, 2025
Manuela Zonca, NeoVac
Tuesday Mar 25, 2025
Tuesday Mar 25, 2025
What happens when a scientist trained in immunology finds herself leading biology at a cutting-edge mRNA Biotech? In this episode of Careers in Discovery, we sit down with Manuela Zonca, VP of Biology at NeoVac, to find out.
Manuela shares her fascinating career journey across Europe - from academia in Spain and France to Biotech leadership in the UK - and the lessons she’s learned along the way. She talks about the importance of following your gut, learning through mistakes, and why adaptability, teamwork, and mentorship are central to scientific success.
We explore Manuela’s role at NeoVac, a clinical-stage company pioneering mRNA delivery for vaccines, autoimmune disease, and more, and how she’s helping expand the platform into new therapeutic areas.
Whether you're thinking about transitioning from academia to industry, building a leadership career in science, or just curious about where mRNA is headed next, this episode is full of insight and inspiration.

Thursday Mar 20, 2025
Jostein Dahle, Blue Wave Therapeutics
Thursday Mar 20, 2025
Thursday Mar 20, 2025
In this episode of Careers in Discovery, we’re joined by Jostein Dahle, Chief Technology Officer at Blue Wave Therapeutics.
Jostein has spent over two decades in radionuclide therapy, taking discoveries from the lab to patients. Now, he's developing a new treatment for glioblastoma, one of the most aggressive and challenging brain cancers, using targeted radionuclide therapy derived from Norwegian seaweed.
We talk about his journey from academia to Biotech, the hard lessons of building and scaling a company, and why following the science, staying agile, and knowing when to walk away are critical in drug discovery.
Jostein also shares his experience of entrepreneurship in Biotech, the challenges of funding innovative treatments, and what’s next for Blue Wave as they move towards the clinic.